Annika Strandell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Annika Strandell has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Mathias Pålsson
Women's Department Carlanderska Hospital Gothenburg Sweden
5 shared publicationsAnnika Idahl
Department of Clinical Sciences, Obstetrics and Gynecology Umeå University Umeå Sweden
4 shared publicationsPer Liv
Department of Public Health and Clinical Medicine, Section of Sustainable Health Umeå University Umeå Sweden
4 shared publications- Annika Idahl
Department of Clinical Sciences, Obstetrics and Gynecology Umeå University Umeå Sweden
3 shared publications - Christina Bergh
Affiliation Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden
3 shared publications Karin Sundfeldt
Department of Obstetrics and Gynecology Institution of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg Gothenburg Sweden
3 shared publications
Latest Publications
- 23 April 2025
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 169 (3) , 1266-1267
Letter to the editor: FIGO Position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy
- 23 April 2025
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 169 (3) , 1266-1267
Letter to the editor: FIGO Position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy
- Open Access
- 22 January 2025
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 132 (6) , 742-751
Managing Pregnancies of Unknown Location With the M4 Prediction Model or the NICE Algorithm: A Randomised Controlled Trial With Cross‐Sectional Diagnostic Accuracy Data
Objective: To determine the diagnostic performance and clinical utility of the M4 prediction model and the NICE algorithm managing women with pregnancy of unknown location (PUL).Design: The study has a superiority design regarding specificity for non‐ectopic pregnancy for M4, given that the primary outcome of sensitivity for ectopic pregnancy (EP) is non‐inferior in comparison with the NICE algorithm.Setting: Emergency gynaecology units in Sweden.Population: 595 women with PUL.Methods: Participants were randomised (1:1) to M4 or the NICE algorithm after two serum human chorionic (hCG) levels and were categorised as high or low risk of having an EP. The diagnostic performance was evaluated on cross‐sectional data and utility by parallel groups.Main Outcome Measures: The proportion of EP categorised as high risk (sensitivity) and non‐ectopic pregnancies categorised as low risk (specificity). Clinical outcomes were assessed.Results: The sensitivity for EP was 79% (115 of 146) for M4 versus 85% (124 of 146) for the NICE algorithm, p = 0.1496 and the specificity for non‐ectopic pregnancies was 67% (300 of 449) for M4 and 74% (334 of 449) for the NICE algorithm, p = 0.0003. Clinical outcomes were similar between groups.Conclusions: The sensitivity for EP by M4 was non‐inferior to NICE, but specificity was better for the NICE algorithm. No between group differences were observed for clinical outcomes.Trial Registration: NCT 03461835, https://www.clinicaltrials.gov
- 22 January 2025
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 132 (6) , 742-751
Open AccessManaging Pregnancies of Unknown Location With the M4 Prediction Model or the NICE Algorithm: A Randomised Controlled Trial With Cross‐Sectional Diagnostic Accuracy Data
Objective: To determine the diagnostic performance and clinical utility of the M4 prediction model and the NICE algorithm managing women with pregnancy of unknown location (PUL).Design: The study has a superiority design regarding specificity for non‐ectopic pregnancy for M4, given that the primary outcome of sensitivity for ectopic pregnancy (EP) is non‐inferior in comparison with the NICE algorithm.Setting: Emergency gynaecology units in Sweden.Population: 595 women with PUL.Methods: Participants were randomised (1:1) to M4 or the NICE algorithm after two serum human chorionic (hCG) levels and were categorised as high or low risk of having an EP. The diagnostic performance was evaluated on cross‐sectional data and utility by parallel groups.Main Outcome Measures: The proportion of EP categorised as high risk (sensitivity) and non‐ectopic pregnancies categorised as low risk (specificity). Clinical outcomes were assessed.Results: The sensitivity for EP was 79% (115 of 146) for M4 versus 85% (124 of 146) for the NICE algorithm, p = 0.1496 and the specificity for non‐ectopic pregnancies was 67% (300 of 449) for M4 and 74% (334 of 449) for the NICE algorithm, p = 0.0003. Clinical outcomes were similar between groups.Conclusions: The sensitivity for EP by M4 was non‐inferior to NICE, but specificity was better for the NICE algorithm. No between group differences were observed for clinical outcomes.Trial Registration: NCT 03461835, https://www.clinicaltrials.gov
- Open Access
- 2 September 2024
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 103 (11) , 2221-2231
Complications after benign gynecologic surgery—How are they captured in register‐based research? A national register study in Sweden
Introduction: The evidence on complication rates after gynecological surgery is based on multiple types of studies, and the level of evidence is generally low. We aimed to validate the registration of complications in the Swedish National Quality Register of Gynecological Surgery (GynOp), by cross‐linkage to multiple national registers.Material and Methods: A national register‐based study using prospectively collected data was conducted, including women who had surgery on the uterus or adnexa for benign indications from January 1, 2017, to December 31, 2020. In Sweden, complications after gynecological surgery are registered in GynOp, and if the complication has rendered any interaction with healthcare, it is also in national health registers. The GynOp register, the National Patient Register, the Prescribed Drugs Register, and the Cause of Death Register were cross‐linked. Complications in GynOp and complications according to ICD10 were analyzed, as well as the cause of death if occurring within 3 months of surgery and prescription of antibiotics ≤30 days. Comparisons between the registries were descriptive.Results: During the study period 32 537 surgeries were performed, of which 26 214 (80.6%) were minimally invasive. Complications were reported in GynOp for 569 women (1.7%) at surgery, 1045 (3.2%) while admitted, and 3868 (13.7%) from discharge to 3 months after surgery. In comparison, according to the Patient Register, 2254 women (6.9%) had postoperative complications within 3 months of discharge (difference of 6.8 percentage points [95% confidence interval 6.2–7.2]). Furthermore, 4117 individuals (12.7%) had a prescription of antibiotics ≤30 days which could indicate a postoperative infection. The rates of hemorrhage, wound dehiscence, and thrombosis were comparable between GynOp and the Patient Register while diagnoses not leading to contact with specialized care had higher rates in the quality register. The coverage of complications was 79.1% in GynOp and 46.1% in the Patient Register, using the total number of complications from both registers as the denominator.Conclusions: A higher frequency of complications is captured in GynOp than in the National Patient Register. Patient‐reported outcomes assessed by a physician are beneficial in identifying complications indicating the importance of structured pre‐defined follow‐up over a set period.
- 2 September 2024
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 103 (11) , 2221-2231
Open AccessComplications after benign gynecologic surgery—How are they captured in register‐based research? A national register study in Sweden
Introduction: The evidence on complication rates after gynecological surgery is based on multiple types of studies, and the level of evidence is generally low. We aimed to validate the registration of complications in the Swedish National Quality Register of Gynecological Surgery (GynOp), by cross‐linkage to multiple national registers.Material and Methods: A national register‐based study using prospectively collected data was conducted, including women who had surgery on the uterus or adnexa for benign indications from January 1, 2017, to December 31, 2020. In Sweden, complications after gynecological surgery are registered in GynOp, and if the complication has rendered any interaction with healthcare, it is also in national health registers. The GynOp register, the National Patient Register, the Prescribed Drugs Register, and the Cause of Death Register were cross‐linked. Complications in GynOp and complications according to ICD10 were analyzed, as well as the cause of death if occurring within 3 months of surgery and prescription of antibiotics ≤30 days. Comparisons between the registries were descriptive.Results: During the study period 32 537 surgeries were performed, of which 26 214 (80.6%) were minimally invasive. Complications were reported in GynOp for 569 women (1.7%) at surgery, 1045 (3.2%) while admitted, and 3868 (13.7%) from discharge to 3 months after surgery. In comparison, according to the Patient Register, 2254 women (6.9%) had postoperative complications within 3 months of discharge (difference of 6.8 percentage points [95% confidence interval 6.2–7.2]). Furthermore, 4117 individuals (12.7%) had a prescription of antibiotics ≤30 days which could indicate a postoperative infection. The rates of hemorrhage, wound dehiscence, and thrombosis were comparable between GynOp and the Patient Register while diagnoses not leading to contact with specialized care had higher rates in the quality register. The coverage of complications was 79.1% in GynOp and 46.1% in the Patient Register, using the total number of complications from both registers as the denominator.Conclusions: A higher frequency of complications is captured in GynOp than in the National Patient Register. Patient‐reported outcomes assessed by a physician are beneficial in identifying complications indicating the importance of structured pre‐defined follow‐up over a set period.
- Open Access
- 11 August 2024
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 45, 101026
Salpingectomy versus tubal occlusion in laparoscopic sterilisation (SALSTER): a national register-based randomised non-inferiority trial
- 11 August 2024
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 45, 101026
Open AccessSalpingectomy versus tubal occlusion in laparoscopic sterilisation (SALSTER): a national register-based randomised non-inferiority trial
- Open Access
SALpingectomy for STERilisation (SALSTER): study protocol for a Swedish multicentre register-based randomised controlled trial
Introduction: Salpingectomy is currently suggested as an alternative to tubal ligation for sterilisation. Precursor lesions of ovarian carcinoma can be found in the fallopian tubes; thus, salpingectomy could possibly reduce the incidence. Most of the existing trials on safety are small, on caesarean section and report on surrogate ovarian function measures. Randomised trials in laparoscopy are lacking. Well-designed trials are needed to evaluate safety of laparoscopic opportunistic salpingectomy.Methods and analysis: In SALSTER, a national register-based randomised controlled non-inferiority trial, 968 women any complicationup to 8 weeks postoperatively, andage at menopause. Both outcomes are measured with questionnaires, complications are also assessed by a gynaecologist. In a nested trial, ovarian function will be evaluated comparing the mean difference of anti-Müllerian hormone (AMH), assessed preoperatively and 1 year after surgery.Ethics and dissemination: Performing salpingectomy for sterilisation has become increasingly common, despite the unclear risk-benefit balance. SALSTER studies the safety of salpingectomy compared with tubal ligation. Regardless of the result, SALSTER will provide gynaecologists with high quality evidence to inform women to decide on salpingectomy or not. The central ethical review board of Gothenburg, Sweden (Dnr. 316–18) approved the trial in 2018. Results will be presented at scientific congresses and published in peer-reviewed scientific journals. The results will be communicated through professional organisations and research networks.Trial registration number: NCT03860805.
Open AccessSALpingectomy for STERilisation (SALSTER): study protocol for a Swedish multicentre register-based randomised controlled trial
Introduction: Salpingectomy is currently suggested as an alternative to tubal ligation for sterilisation. Precursor lesions of ovarian carcinoma can be found in the fallopian tubes; thus, salpingectomy could possibly reduce the incidence. Most of the existing trials on safety are small, on caesarean section and report on surrogate ovarian function measures. Randomised trials in laparoscopy are lacking. Well-designed trials are needed to evaluate safety of laparoscopic opportunistic salpingectomy.Methods and analysis: In SALSTER, a national register-based randomised controlled non-inferiority trial, 968 women any complicationup to 8 weeks postoperatively, andage at menopause. Both outcomes are measured with questionnaires, complications are also assessed by a gynaecologist. In a nested trial, ovarian function will be evaluated comparing the mean difference of anti-Müllerian hormone (AMH), assessed preoperatively and 1 year after surgery.Ethics and dissemination: Performing salpingectomy for sterilisation has become increasingly common, despite the unclear risk-benefit balance. SALSTER studies the safety of salpingectomy compared with tubal ligation. Regardless of the result, SALSTER will provide gynaecologists with high quality evidence to inform women to decide on salpingectomy or not. The central ethical review board of Gothenburg, Sweden (Dnr. 316–18) approved the trial in 2018. Results will be presented at scientific congresses and published in peer-reviewed scientific journals. The results will be communicated through professional organisations and research networks.Trial registration number: NCT03860805.
- Open Access
- 23 August 2023
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 102 (11) , 1479-1487
Physicians' assessment of complications after gynecological surgery in Sweden: The GYNCOM survey
Introduction: Complications after gynecological surgery in Sweden are registered in the well‐established Swedish National Quality Register of Gynecological Surgery, GynOp. The aim of this study was to analyze interrater reliability in assessing complications according to the methods in GynOp, and to explore physicians' perceptions of registering complications.Material and methods: A digital survey was sent to gynecologists and residents in gynecology in Sweden. Participating clinics were recruited through the Swedish network for national clinical studies in Obstetrics and Gynecology, SNAKS. Twenty fictional cases, intended to represent normal postoperative course, failure to cure, and varying degrees of complications, were developed by the research group. The clinical scenarios included abdominal and laparoscopic surgery of the uterus and adnexa, vaginal hysterectomies, as well as hysteroscopy. The respondents graded each case on the presence of a complication (yes/no). Type of complication, severity, and what action the complication required according to Clavien‐Dindo was registered if a complication was acknowledged, according to the method in GynOp. Interrater reliability and the opinions of the respondents were presented descriptively. More than 80% of respondents making the same assessment was considered as agreement.Results: The response rate was 41%, with 104 responding physicians from 16 gynecological clinics. Type and severity of complication was considered relevant to register by 88% and 89% of respondents, respectively. Agreement on whether the case described a complication was >80% in 85% (17/20) of cases and agreement using the Clavien‐Dindo classification was >90% in 80% (16/20) of cases. There was high agreement in assessments of classically severe complications, such as pulmonary embolism and ureteral damage, in both presence of complication and severity, as well as Clavien‐Dindo (>90% for all methods). Cases with agreement <80% on whether the case described a complication were bordering between normal postoperative course and minor complication.Conclusions: This study provides validation for the methods used to register complications after gynecological surgery according to the GynOp register, including the use of Clavien‐Dindo in gynecology. However, the results indicate a need to define what should be considered symptoms inherent to each type of surgery.
- 23 August 2023
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 102 (11) , 1479-1487
Open AccessPhysicians' assessment of complications after gynecological surgery in Sweden: The GYNCOM survey
Introduction: Complications after gynecological surgery in Sweden are registered in the well‐established Swedish National Quality Register of Gynecological Surgery, GynOp. The aim of this study was to analyze interrater reliability in assessing complications according to the methods in GynOp, and to explore physicians' perceptions of registering complications.Material and methods: A digital survey was sent to gynecologists and residents in gynecology in Sweden. Participating clinics were recruited through the Swedish network for national clinical studies in Obstetrics and Gynecology, SNAKS. Twenty fictional cases, intended to represent normal postoperative course, failure to cure, and varying degrees of complications, were developed by the research group. The clinical scenarios included abdominal and laparoscopic surgery of the uterus and adnexa, vaginal hysterectomies, as well as hysteroscopy. The respondents graded each case on the presence of a complication (yes/no). Type of complication, severity, and what action the complication required according to Clavien‐Dindo was registered if a complication was acknowledged, according to the method in GynOp. Interrater reliability and the opinions of the respondents were presented descriptively. More than 80% of respondents making the same assessment was considered as agreement.Results: The response rate was 41%, with 104 responding physicians from 16 gynecological clinics. Type and severity of complication was considered relevant to register by 88% and 89% of respondents, respectively. Agreement on whether the case described a complication was >80% in 85% (17/20) of cases and agreement using the Clavien‐Dindo classification was >90% in 80% (16/20) of cases. There was high agreement in assessments of classically severe complications, such as pulmonary embolism and ureteral damage, in both presence of complication and severity, as well as Clavien‐Dindo (>90% for all methods). Cases with agreement <80% on whether the case described a complication were bordering between normal postoperative course and minor complication.Conclusions: This study provides validation for the methods used to register complications after gynecological surgery according to the GynOp register, including the use of Clavien‐Dindo in gynecology. However, the results indicate a need to define what should be considered symptoms inherent to each type of surgery.
- 29 June 2023
- Published by Elsevier in The Lancet
- Vol. 402 (10395) , 6-7
Time to stop routine prescription of low-molecular-weight heparin to women with recurrent pregnancy loss and inherited thrombophilia
- 29 June 2023
- Published by Elsevier in The Lancet
- Vol. 402 (10395) , 6-7
Time to stop routine prescription of low-molecular-weight heparin to women with recurrent pregnancy loss and inherited thrombophilia
- Open Access
- 9 January 2023
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 161 (2) , 343-355
Safety, effectiveness, womenʼs experience, and economic costs of outpatient induction in women with uncomplicated pregnancies: A systematic review and meta‐analyses
Background: Induction of labor is increasing worldwide, and some countries have started to introduce outpatient induction in low‐risk women.Objectives: To assess current knowledge concerning the safety, efficacy, women's experience, and economic costs of outpatient induction compared with inpatient induction.Search strategy: Multiple databases were last searched on October 19, 2021. Studies were selected according to our pre‐specified inclusion, selection, and exclusion criteria.Selection criteria: PICO; P—women with low‐risk pregnancy planned for induction of labor. I—Outpatient induction C—Inpatient induction O—Outcomes according to the core outcome set for induction of labor (COSIOL).Data collection and analysis: Pooled in meta‐analyses. The certainty of evidence was assessed using the GRADE system.Main results: The 20 included studies, including 7956 women, showed an overall low incidence of adverse events and indicated comparable results for inpatient and outpatient induction, but the studies were underpowered for safety‐related outcomes. Women's experiences of outpatient induction were mostly positive. Based on three studies, the economic costs consequence is inconclusive.Conclusions: Due to early randomization, heterogenic study design, and underpowered studies regarding safety outcome, the certainty of evidence is very low. It is uncertain whether outpatient induction affects the risk for neonatal and maternal complications.
- 9 January 2023
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 161 (2) , 343-355
Open AccessSafety, effectiveness, womenʼs experience, and economic costs of outpatient induction in women with uncomplicated pregnancies: A systematic review and meta‐analyses
Background: Induction of labor is increasing worldwide, and some countries have started to introduce outpatient induction in low‐risk women.Objectives: To assess current knowledge concerning the safety, efficacy, women's experience, and economic costs of outpatient induction compared with inpatient induction.Search strategy: Multiple databases were last searched on October 19, 2021. Studies were selected according to our pre‐specified inclusion, selection, and exclusion criteria.Selection criteria: PICO; P—women with low‐risk pregnancy planned for induction of labor. I—Outpatient induction C—Inpatient induction O—Outcomes according to the core outcome set for induction of labor (COSIOL).Data collection and analysis: Pooled in meta‐analyses. The certainty of evidence was assessed using the GRADE system.Main results: The 20 included studies, including 7956 women, showed an overall low incidence of adverse events and indicated comparable results for inpatient and outpatient induction, but the studies were underpowered for safety‐related outcomes. Women's experiences of outpatient induction were mostly positive. Based on three studies, the economic costs consequence is inconclusive.Conclusions: Due to early randomization, heterogenic study design, and underpowered studies regarding safety outcome, the certainty of evidence is very low. It is uncertain whether outpatient induction affects the risk for neonatal and maternal complications.
- Open Access
- 27 May 2022
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 101 (6) , 564-576
Term breech presentation—Intended cesarean section versus intended vaginal delivery—A systematic review and meta‐analysis
Introduction: Three per cent of all infants are born in breech presentation, still the preferred way to deliver them remains controversial. The objective of this systematic review was to assess the safety for the mother and child depending on intended mode of delivery when the baby is in breech position at term.Material and Methods: The population (P) was pregnant women with a child in breech presentation, from gestational week 34+0. The intervention (I) was the intention to deliver by cesarean section, the comparison (C) was the intention to deliver vaginally. Outcomes (O) were perinatal mortality, perinatal morbidity, maternal mortality, maternal morbidity, conversion of delivery mode, and the mother's experience. Systematic literature searches were performed. We included randomized trials, cohort studies with more than 500 women/group and case series for more than 15 000 women published between 1990 and October 2021, written in English or the Nordic languages. The certainty of evidence was assessed using the GRADE approach and data were pooled in meta‐analyses. PROSPERO registration number: CRD42020209546.Results: Thirty‐two articles were included (with 530 604 women). The certainty of evidence was moderate or low because the study designs were mostly retrospective cohort studies. The only randomized trial showed reduced risk of perinatal mortality for planned cesarean section, risk ratio (RR) 0.27 (95% confidence interval [CI] 0.08–0.97, 2078 women, low certainty of evidence), stillbirths excluded. A meta‐analysis of cohort studies resulted in a similar estimate, RR 0.36 (95% CI 0.25–0.51, 21 studies, 388 714 women, low certainty of evidence). We also found reduced risk for outcomes representing perinatal morbidity 0–28 days: 5‐min Apgar score less than 7 in one randomized controlled trial: RR 0.27 (95% CI 0.12–0.58, 2033 women, moderate certainty of evidence), and in a meta‐analysis: RR 0.1 (95% CI 0.14–0.26, 18 studies, 217 024 women, moderate certainty of evidence); APGAR score less than 4 at 5 min: RR 0.39 (95% CI 0.19–0.81, five studies, 44 498 women, low certainty of evidence); and pH less than 7.0: RR 0.23 (95% CI 0.12–0.43, four studies, 13 440 women, low certainty of evidence). Outcomes for the mother were similar in the groups except for reduced risk for experience of urinary incontinence in the group of planned cesarean section: RR 0.62 (95% CI 0.41–0.93, one study, 1940 women, low certainty of evidence). The conversion rate from planned vaginal delivery to emergency cesarean section ranged from 16% to 51% (median 41.8%, 10 studies, 50 763 women, moderate certainty of evidence).Conclusions: Intended cesarean section may reduce the risk of perinatal mortality and perinatal as well as some maternal morbidity compared with intended vaginal delivery. It is uncertain whether there is any difference in maternal mortality. The conversion rate from intended vaginal delivery to emergency cesarean section is high.
- 27 May 2022
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 101 (6) , 564-576
Open AccessTerm breech presentation—Intended cesarean section versus intended vaginal delivery—A systematic review and meta‐analysis
Introduction: Three per cent of all infants are born in breech presentation, still the preferred way to deliver them remains controversial. The objective of this systematic review was to assess the safety for the mother and child depending on intended mode of delivery when the baby is in breech position at term.Material and Methods: The population (P) was pregnant women with a child in breech presentation, from gestational week 34+0. The intervention (I) was the intention to deliver by cesarean section, the comparison (C) was the intention to deliver vaginally. Outcomes (O) were perinatal mortality, perinatal morbidity, maternal mortality, maternal morbidity, conversion of delivery mode, and the mother's experience. Systematic literature searches were performed. We included randomized trials, cohort studies with more than 500 women/group and case series for more than 15 000 women published between 1990 and October 2021, written in English or the Nordic languages. The certainty of evidence was assessed using the GRADE approach and data were pooled in meta‐analyses. PROSPERO registration number: CRD42020209546.Results: Thirty‐two articles were included (with 530 604 women). The certainty of evidence was moderate or low because the study designs were mostly retrospective cohort studies. The only randomized trial showed reduced risk of perinatal mortality for planned cesarean section, risk ratio (RR) 0.27 (95% confidence interval [CI] 0.08–0.97, 2078 women, low certainty of evidence), stillbirths excluded. A meta‐analysis of cohort studies resulted in a similar estimate, RR 0.36 (95% CI 0.25–0.51, 21 studies, 388 714 women, low certainty of evidence). We also found reduced risk for outcomes representing perinatal morbidity 0–28 days: 5‐min Apgar score less than 7 in one randomized controlled trial: RR 0.27 (95% CI 0.12–0.58, 2033 women, moderate certainty of evidence), and in a meta‐analysis: RR 0.1 (95% CI 0.14–0.26, 18 studies, 217 024 women, moderate certainty of evidence); APGAR score less than 4 at 5 min: RR 0.39 (95% CI 0.19–0.81, five studies, 44 498 women, low certainty of evidence); and pH less than 7.0: RR 0.23 (95% CI 0.12–0.43, four studies, 13 440 women, low certainty of evidence). Outcomes for the mother were similar in the groups except for reduced risk for experience of urinary incontinence in the group of planned cesarean section: RR 0.62 (95% CI 0.41–0.93, one study, 1940 women, low certainty of evidence). The conversion rate from planned vaginal delivery to emergency cesarean section ranged from 16% to 51% (median 41.8%, 10 studies, 50 763 women, moderate certainty of evidence).Conclusions: Intended cesarean section may reduce the risk of perinatal mortality and perinatal as well as some maternal morbidity compared with intended vaginal delivery. It is uncertain whether there is any difference in maternal mortality. The conversion rate from intended vaginal delivery to emergency cesarean section is high.